Abstract 4-(5-Arylidene-2,4-dioxothiazolidin-3-yl)methylbenzoic acids (2) were synthesized and evaluated in vitro as inhibitors of PTP1B and LMW-PTP, two protein tyrosine phosphatases (PTPs) which act as negative regulators of the metabolic and mitotic signalling of insulin. The synthesis of compounds 2 represents an example of utilizing phosphotyrosine-mimetics to identify effective low molecular weight nonphosphorus inhibitors of PTPs. Several thiazolidinediones 2 exhibited PTP1B inhibitory activity in the low micromolar range with moderate selectivity for human PTP1B and IF1 isoform of human LMW-PTP compared with other related PTPs.
5-Arylidene- 2,4-Thiazolidinediones Inhibitors of Protein Tyrosine Phosphatases / R.Maccari; P.Paoli; R.Ottanà; M.Jacomelli; R.Ciurleo; G.Manao; T.Steindl; T.Langer; M.Vigorita; G.Camici. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 1464-3391. - STAMPA. - 15:(2007), pp. 5137-5149. [10.1016/j.bmc.2007.05.027]
5-Arylidene- 2,4-Thiazolidinediones Inhibitors of Protein Tyrosine Phosphatases
PAOLI, PAOLO;MANAO, GIAMPAOLO;CAMICI, GUIDO
2007
Abstract
Abstract 4-(5-Arylidene-2,4-dioxothiazolidin-3-yl)methylbenzoic acids (2) were synthesized and evaluated in vitro as inhibitors of PTP1B and LMW-PTP, two protein tyrosine phosphatases (PTPs) which act as negative regulators of the metabolic and mitotic signalling of insulin. The synthesis of compounds 2 represents an example of utilizing phosphotyrosine-mimetics to identify effective low molecular weight nonphosphorus inhibitors of PTPs. Several thiazolidinediones 2 exhibited PTP1B inhibitory activity in the low micromolar range with moderate selectivity for human PTP1B and IF1 isoform of human LMW-PTP compared with other related PTPs.File | Dimensione | Formato | |
---|---|---|---|
ID 315501 BIOORG MED CHEM 2007.pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
DRM non definito
Dimensione
740.44 kB
Formato
Adobe PDF
|
740.44 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.